During the past decade, Comprehensive Hemophilia Care Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Comprehensive Hemophilia Care Center" are "Hemophilia A With Inhibitor" (1 trials), "Hemophilia A or B With Inhibitor" (1 trials) and "Hemophilia B With Inhibitor" (1 trials). Many other conditions were trialed in "Comprehensive Hemophilia Care Center" in a lesser frequency.

Most popular intervention types in "Comprehensive Hemophilia Care Center" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Biosimilar eptacog alfa, activated (AryoSeven)" (1 trials), "Eptacog alfa, activated" (1 trials) and "Eptacog alfa, activated (Novoseven)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Hemophilia Care Center" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Comprehensive Hemophilia Care Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Comprehensive Hemophilia Care Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Hemophilia Care Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".